These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5641667)

  • 1. Quantitative analysis of pharmaceutical preparations by x-ray diffractometry. 8. Direct quantitative x-ray diffraction analysis of oral suspensions.
    Kuroda K; Hashizume G; Fukuda K
    J Pharm Sci; 1968 Feb; 57(2):250-4. PubMed ID: 5641667
    [No Abstract]   [Full Text] [Related]  

  • 2. [X-ray diffraction applied to the study of the structure of pharmacologically active substances].
    Covello M; Silipo C; Vittoria A
    Boll Chim Farm; 1971 Apr; 110(4):183-96 contd. PubMed ID: 5111344
    [No Abstract]   [Full Text] [Related]  

  • 3. Coulometric determination of sulfadimethoxine and sulfafurazole.
    Nikolić K; Medenica M
    Acta Pol Pharm; 1990; 47(1-2):11-3. PubMed ID: 12959251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLC identification of sulfonamides.
    Klein HR; Mader WJ
    J Pharm Sci; 1971 Mar; 60(3):448-50. PubMed ID: 5109798
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative determination of famotidine polymorphs: X-ray powder diffractometric and Raman spectrometric study.
    Német Z; Kis GC; Pokol G; Demeter A
    J Pharm Biomed Anal; 2009 Feb; 49(2):338-46. PubMed ID: 19131203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quantitative analysis of pharmaceutical preparations by X-ray diffractometry. VII. Quantitative analysis of suspensions by internal standard method].
    Kuroda K; Hashizume G; Fududa K
    Yakugaku Zasshi; 1967 Dec; 87(12):1562-8. PubMed ID: 5628372
    [No Abstract]   [Full Text] [Related]  

  • 7. [Methods for quantitative determination of sulfanilamide preparations].
    Guseva LN
    Aptechn Delo; 1966; 15(4):74-8. PubMed ID: 4866578
    [No Abstract]   [Full Text] [Related]  

  • 8. [Morphological and structural aspects of solid drug forms].
    Bettinetti G
    Boll Chim Farm; 1991 Mar; 130(3):85-8. PubMed ID: 1892610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differential thermal analysis and X-ray diffraction patterns of some poorly soluble drugs fixed onto silicon dioxide (author's transl)].
    Remon JP; Van Severen R; Braeckman P
    J Pharm Belg; 1979; 34(2):77-82. PubMed ID: 229207
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of high sensitivity micro differential scanning calorimetry with X-ray powder diffractometry and FTIR spectroscopy for the characterization of pharmaceutically relevant non-crystalline materials.
    Song M; Liebenberg W; De Villiers MM
    Pharmazie; 2006 Apr; 61(4):336-40. PubMed ID: 16649550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quantitative analysis of pharmaceutical preparations by x-ray diffractometry. VI. Quantitative analysis of vaginal tablets].
    Kuroda K; Hashizume G; Fukuda K
    Yakugaku Zasshi; 1967 Oct; 87(10):1175-83. PubMed ID: 5626984
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative determination of polymorphic impurity by X-ray powder diffractometry in an OROS formulation.
    Varasteh M; Deng Z; Hwang H; Kim YJ; Wong GB
    Int J Pharm; 2009 Jan; 366(1-2):74-81. PubMed ID: 18840515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing the signal-to-noise ratio of X-ray diffraction profiles by smoothed principal component analysis.
    Chen ZP; Morris J; Martin E; Hammond RB; Lai X; Ma C; Purba E; Roberts KJ; Bytheway R
    Anal Chem; 2005 Oct; 77(20):6563-70. PubMed ID: 16223241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [X-ray diffractometry in the analysis of pharmaceutical products: phenomena of indomethacin polymorphism].
    Zannetti R; Marigo A; Guerrato A; Bortoletti B
    Boll Chim Farm; 1986 Jun; 125(6):180-9. PubMed ID: 3801163
    [No Abstract]   [Full Text] [Related]  

  • 15. Spray coated pellets as carrier system for mucoadhesive drug nanocrystals.
    Möschwitzer J; Müller RH
    Eur J Pharm Biopharm; 2006 Apr; 62(3):282-7. PubMed ID: 16377161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative determination of polymorphic composition in intact compacts by parallel-beam X-ray powder diffractometry II. Data correction for analysis of phase transformations as a function of pressure.
    Wildfong PL; Morley NA; Moore MD; Morris KR
    J Pharm Biomed Anal; 2005 Sep; 39(1-2):1-7. PubMed ID: 15869857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Method and reliability of crystallographic stone analysis.
    Otnes B; Montgomery O
    Invest Urol; 1980 Jan; 17(4):314-9. PubMed ID: 7351364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of pharmaceutical preparations by x-ray diffractometry. X. Direct quantitative x-ray diffraction analysis of ethionamide in rectal suppositories.
    Kuroda K; Hashizume G
    Chem Pharm Bull (Tokyo); 1972 Sep; 20(9):2059-62. PubMed ID: 4645224
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of chemometric algorithms in quantitative X-ray powder diffraction (XRPD) of intact multi-component consolidated samples.
    Moore MD; Cogdill RP; Wildfong PL
    J Pharm Biomed Anal; 2009 Apr; 49(3):619-26. PubMed ID: 19167855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of pharmaceutical preparations by X-ray diffractometry. IX. Direct quantitative X-ray diffraction analysis of salicylic acid plaster.
    Kuroda K; Hashizume G; Kume F
    Chem Pharm Bull (Tokyo); 1969 Apr; 17(4):818-21. PubMed ID: 5806900
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.